SEC Form 4 · accession 0001127602-18-007529
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helena Foulkes
Officer — EVP & President-CVS Pharmacy
Period of report
Feb 16, 2018
Accepted (ET)
Feb 21, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2018 | M | 19,965 | $45.07 | A | 65,072 | D | |
| Common Stock | Feb 16, 2018 | S | 19,965 | $71.04 | D | 45,107 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $45.07 | Feb 16, 2018 | M | 19,965 | D | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 19,965 | 0 | D |
Explanation of responses
- F1Option became exercisable in four equal annual installments, commencing 4/2/2013.